Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia

OBJECTIVE: To evaluate the efficacy and safety of gonadotropin-releasing hormone agonist (GnRHa) combined with a levonorgestrel-releasing intrauterine device (LNG-IUD) or aromatase inhibitor (letrozole) in women with endometrial carcinoma or atypical endometrial hyperplasia who wished to preserve fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junyu, Cao, Dongyan, Yang, Jiaxin, Yu, Mei, Zhou, Huimei, Cheng, Ninghai, Wang, Jinhui, Zhang, Ying, Peng, Peng, Shen, Keng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763228/
https://www.ncbi.nlm.nih.gov/pubmed/36368706
http://dx.doi.org/10.1136/ijgc-2022-003882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763228/
https://www.ncbi.nlm.nih.gov/pubmed/36368706
http://dx.doi.org/10.1136/ijgc-2022-003882

Ejemplares similares